Clinical Trials Browser

Phase 3 × INDUSTRY × necitumumab × Clear all

NCT00981058 2025-06-18

SQUIRE

Phase 3 Completed

1,093 enrolled 24 charts

Carcinoma, Non-Small-Cell Lung

NCT00982111 2022-01-11

INSPIRE

Phase 3 Completed

633 enrolled 25 charts

Carcinoma, Non-Small-Cell Lung